Identification of a competing risks model with unknown transformations of latent failure times [PDF]
This paper is concerned with identification of a competing risks model with unknown transformations of latent failure times. The model in this paper includes, as special cases, competing risks versions of proportional hazards, mixed proportional ...
Lee, S., Lee, Sokbae, Sokbae (Simon) Lee
core +1 more source
Background Guidelines recommend shared decision making (SDM) for mammography screening for women ≥ 75 and not screening women with 55 years who completed the 2004 Nurses’ Health Study (NHS) questionnaire, we developed (in 2/3 of the cohort, n = 55,533 ...
Mara A. Schonberg +7 more
doaj +1 more source
Association between duration of gonadotrophin-releasing hormone agonist use and cardiovascular risks: A population-based competing-risk analysis [PDF]
Background Although androgen deprivation therapy has known cardiovascular risks, it is unclear if its duration is related to cardiovascular risks.
Kenrick +8 more
core +1 more source
Competing risks, left truncation and late entry effect in A-bomb survivors cohort [PDF]
The cohort under study comprises A-bomb survivors residing in Hiroshima Prefecture since 1968. After this year, thousands of survivors were newly recognized every year.
Anzures-Cabrera, J., Hutton, Jane
core +1 more source
Are competing risks models appropriate to describe implant failure?
Background and purpose — The use of competing risks models is widely advocated in the arthroplasty literature due to a perceived bias in comparison of simple Kaplan–Meier estimates.
Adrian Sayers +3 more
doaj +2 more sources
Using competing risks model and competing events in outcome of pulmonary tuberculosis patients
Introduction: Although tuberculosis (TB) is curable, the rate of failure and mortality is high in comparison to other infectious diseases worldwide. It has been shown that majority of TB patients leave treatment before completing the therapeutic regimen.
Mehdi Kazempour Dizaji +3 more
doaj +1 more source
Competing risks data in clinical oncology
Competing risks data analysis plays a critical role in the evaluation of clinical utility of specific cancer treatments and can inform the development of future treatment approaches.
Haesook Teresa Kim
doaj +1 more source
Understanding competing risks: a simulation point of view
Background Competing risks methodology allows for an event-specific analysis of the single components of composite time-to-event endpoints. A key feature of competing risks is that there are as many hazards as there are competing risks.
Wanner Christoph +4 more
doaj +1 more source
Competing risk models to estimate the excess mortality and the first recurrent-event hazards [PDF]
Background In medical research, one common competing risks situation is the study of different types of events, such as disease recurrence and death. We focused on that situation but considered death under two aspects: "expected death" and "excess death",
Belot Aurélien +14 more
core +2 more sources
Competing-risks model for pre-eclampsia and adverse pregnancy outcomes.
The competing risks model for assessment of risk for pre-eclampsia (PE) at 35-36 weeks' gestation identifies the majority of women whose pregnancies are at high-risk for subsequent delivery with PE. To objective of this study was to examine, according to
Wright, A +6 more
core +1 more source

